NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma.
Moustafa S Ghanem, Debora Soncini, Claudia Martinuzzi, Sara Aquino, Antonia Cagnetta, Pamela Becherini, Michele Cea, Fiammetta Monacelli, Luca Mastracci, Aimable Nahimana, Michel A Duchosal, Alessio Nencioni, Fabio Guolo, Gianluca Santamaria, Silvia Ravera, Emanuele Angelucci, Francesco Piacente, Santina Bruzzone, Claudia Veneziano, Francesco Ladisa, Adithya Chedere, Elisa Gelli, Giulia Giorgetti, Matteo Garibotto, Mario Passalaqua, Axel Bellotti, Chandra Nagasuma, Roberto Massimo Lemoli
Blood advances 2025;9(5):1024-1039